Blood Cancer News and Research

RSS
Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Study suggests new strategy to kill melanoma cells

Study suggests new strategy to kill melanoma cells

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Gene types that drive racial disparities in myeloma identified

Gene types that drive racial disparities in myeloma identified

'Supercharged' immune cells could help fight cancer

'Supercharged' immune cells could help fight cancer

Study sheds light on transport of enzyme involved in stem cell differentiation to DNA

Study sheds light on transport of enzyme involved in stem cell differentiation to DNA

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Research shows possibility to postpone cumbersome treatment for low-risk MDS patients

Research shows possibility to postpone cumbersome treatment for low-risk MDS patients

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

Progenitor cells for human bone and cartilage have been identified

Progenitor cells for human bone and cartilage have been identified

UK and European research collaborations receive vote of confidence by three major cancer charities

UK and European research collaborations receive vote of confidence by three major cancer charities

FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

Novel treatment for hairy cell leukemia approved by FDA

Novel treatment for hairy cell leukemia approved by FDA

Drug combination targets pre-leukemia stem cells

Drug combination targets pre-leukemia stem cells

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

People with blood cancer less likely to understand their diagnosis

People with blood cancer less likely to understand their diagnosis

NUS scientists develop new technology to customize optimal drug ‘cocktail’ for myeloma patients

NUS scientists develop new technology to customize optimal drug ‘cocktail’ for myeloma patients